Catherine Leger
Impact in
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
-
- Genetic factors in colorectal cancer
Papers in
- Oncology 9
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 6
- Neutropenia and Cancer Infections 2
- Pancreatic and Hepatic Oncology Research 2
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Nadia Amellal (8 shared papers)Josep Tabernero (8 shared papers)Eric Van Cutsem (5 shared papers)Marwan Fakih (3 shared papers)Julien Taı̈eb (3 shared papers)Fortunato Ciardiello (3 shared papers)Gerald W. Prager (4 shared papers)Lucjan Wyrwicz (2 shared papers)
In The Last Decade
Catherine Leger
9 papers receiving 257 citations
Catherine Leger's Hit Papers
Peers
Comparison fields: 5 of 46
- Oncology 216
- Pathology and Forensic Medicine 77
- Hepatology 28
- Pulmonary and Respiratory Medicine 96
- Cancer Research 33
Countries citing papers authored by Catherine Leger
This map shows the geographic impact of Catherine Leger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Leger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Leger more than expected).
Fields of papers citing papers by Catherine Leger
This network shows the impact of papers produced by Catherine Leger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Leger. The network helps show where Catherine Leger may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Leger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2023 | 183 |
| 2 | 2021 | 32 | |
| 3 | 2023 | 27 | |
| 4 | 2019 | 8 | |
| 5 | 2018 | 4 | |
| 6 | 2019 | 4 | |
| 7 | 2017 | 2 | |
| 8 | 1996 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 2017 | 1 |
About Catherine Leger
Catherine Leger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Management of Technology and Innovation and Archeology, having authored 10 papers that have together received 263 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (6 papers), Gastric Cancer Management and Outcomes (4 papers), Genetic factors in colorectal cancer (2 papers), Neutropenia and Cancer Infections (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Family Business Performance and Succession (1 paper). The work is most often cited by research in Oncology (216 citations), Pathology and Forensic Medicine (77 citations), Hepatology (28 citations), Pulmonary and Respiratory Medicine (96 citations) and Cancer Research (33 citations). Catherine Leger has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Nadia Amellal, Josep Tabernero, Eric Van Cutsem, Marwan Fakih, Julien Taı̈eb, Fortunato Ciardiello, Gerald W. Prager, Lucjan Wyrwicz, Pierre-Guillaume Poureau and Felipe Melo Cruz. Their work appears in journals such as Journal of Clinical Oncology, Entreprises et histoire, Future Oncology, New England Journal of Medicine and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.